MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identification

National Institutes of Health (NIH)
A novel, disposable infrared (IR)-transparent membrane and methods for making and using this membrane to identify bacterial and other microorganism impurities in food using IR spectroscopy.

Full description

Available for licensing and commercial development is a novel, disposable infrared (IR)-transparent, microporous, plasma treated polyethylene hydrophilic membrane, as well as methods for making and using this membrane to identify bacterial and other microorganism impurities in food using IR spectroscopy.  Further applications include: filtering dilute aqueous bacterial suspensions, and growing bacterial colonies when the PE membrane is placed over an agar medium and incubated.  The patent also describes a novel high-throughout technique, as an alternative to manual filtration, where the PE membrane is used for microarray printing of intact microorganisms in pre-enriched medium on the treated PE substrate.  Furthermore, the invention relates to a method of detecting mixtures of food-borne pathogens E. sakazakii and K. pneumonia, by using the treated PE membranes.  Because this unique membrane is transparent to infrared light, isolated microcolonies of bacterial cells grown on this PE substrate can be fingerprinted directly by IR microspectroscopy, followed by multivariate analysis for the identification of the pathogens. The method can be applied to other cell types as well.

 

This novel membrane and its applications offer an advantage over existing tests in that it can be used to rapidly identify presumptive pathogen colonies, and can be used in screening tests for a large number of pathogens, as well as various microorganisms and cell types.  It can also be used to isolate microorganisms from aqueous suspensions as well as spores, including airborne ones.

Patent information

U.S. Patent Application No. 11/343,561 filed 30 Jan 2006 (HHS Reference No. E-174-2005/0-US-01)

U.S. Patent Application No. 12/150,048 filed 23 Apr 2008 (HHS Reference No. E-174-2005/0-US-02)

Inventors: 

Magdi M. Mossoba and Sufian Al-Khaldi (FDA) 

 

 

 

Type of business relationship sought

Licensees Sought: 

Available for non-exclusive or exclusive licensing.

Licensing contact

Jeffrey James
Licensing and Patenting Associate
Office of Technology Transfer

Contact directly

Company details

National Institutes of Health (NIH)

The NIH supports and conducts basic, clinical, and translational medical research, and investigates the causes, treatments, and cures for both common and rare diseases.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us